JP2021533085A5 - - Google Patents
Info
- Publication number
- JP2021533085A5 JP2021533085A5 JP2020571480A JP2020571480A JP2021533085A5 JP 2021533085 A5 JP2021533085 A5 JP 2021533085A5 JP 2020571480 A JP2020571480 A JP 2020571480A JP 2020571480 A JP2020571480 A JP 2020571480A JP 2021533085 A5 JP2021533085 A5 JP 2021533085A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- compound according
- optionally substituted
- alkoxy
- haloalkyl
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1810071.9A GB201810071D0 (en) | 2018-06-19 | 2018-06-19 | Compounds |
| GB1810071.9 | 2018-06-19 | ||
| PCT/GB2019/051728 WO2019243822A1 (en) | 2018-06-19 | 2019-06-19 | 1,2,4-triazole derivatives as tankyrase inhibitors |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021533085A JP2021533085A (ja) | 2021-12-02 |
| JP2021533085A5 true JP2021533085A5 (https=) | 2022-06-24 |
| JPWO2019243822A5 JPWO2019243822A5 (https=) | 2022-06-24 |
| JP7445266B2 JP7445266B2 (ja) | 2024-03-07 |
Family
ID=63042576
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020571480A Active JP7445266B2 (ja) | 2018-06-19 | 2019-06-19 | タンキラーゼ阻害剤としての１，２，４－トリアゾール誘導体 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US11926614B2 (https=) |
| EP (1) | EP3810597B1 (https=) |
| JP (1) | JP7445266B2 (https=) |
| KR (1) | KR20210024019A (https=) |
| CN (1) | CN112469714B (https=) |
| CA (1) | CA3103879A1 (https=) |
| ES (1) | ES3056990T3 (https=) |
| GB (1) | GB201810071D0 (https=) |
| WO (1) | WO2019243822A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202010359D0 (en) * | 2020-07-06 | 2020-08-19 | Univ Oslo Hf | Compounds |
| EP4247811A1 (en) * | 2020-11-19 | 2023-09-27 | F. Hoffmann-La Roche AG | Bicyclo[1.1.1]pentane compounds for the treatment and prophylaxis of hepatitis b virus infection |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4302051A1 (de) * | 1993-01-26 | 1994-07-28 | Thomae Gmbh Dr K | 5-gliedrige Heterocyclen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| WO2010139966A1 (en) | 2009-06-05 | 2010-12-09 | Oslo University Hospital Hf | Azole derivatives as wtn pathway inhibitors |
| JP2013544874A (ja) | 2010-12-08 | 2013-12-19 | オスロ ユニヴァーシティー ホスピタル エイチエフ | Ｗｎｔシグナル伝達経路阻害薬としてのトリアゾール誘導体 |
| MA41253A (fr) | 2014-12-23 | 2017-10-31 | Proteostasis Therapeutics Inc | Composés, compositions et procédés pour augmenter l'activité du cftr |
| US10392378B2 (en) | 2014-12-23 | 2019-08-27 | Proteostasis Therapeutics, Inc. | Derivatives of 5-phenyl- or 5-heteroarylathiazol-2-carboxylic amide useful for the treatment of inter alia cystic fibrosis |
| WO2018118868A1 (en) | 2016-12-19 | 2018-06-28 | Oslo University Hospital Hf | Triazole derivatives as tankyrase inhibitors |
-
2018
- 2018-06-19 GB GBGB1810071.9A patent/GB201810071D0/en not_active Ceased
-
2019
- 2019-06-19 WO PCT/GB2019/051728 patent/WO2019243822A1/en not_active Ceased
- 2019-06-19 ES ES19734147T patent/ES3056990T3/es active Active
- 2019-06-19 JP JP2020571480A patent/JP7445266B2/ja active Active
- 2019-06-19 CA CA3103879A patent/CA3103879A1/en active Pending
- 2019-06-19 US US17/253,668 patent/US11926614B2/en active Active
- 2019-06-19 CN CN201980048153.4A patent/CN112469714B/zh active Active
- 2019-06-19 EP EP19734147.2A patent/EP3810597B1/en active Active
- 2019-06-19 KR KR1020217001542A patent/KR20210024019A/ko not_active Ceased